Non-Myelofibrosis Chronic Myeloproliferative Neoplasm Patients Show Better Seroconversion Rates after SARS-CoV-2 Vaccination Compared to Other Hematologic Diseases: A Multicentric Prospective Study of KroHem.

Autor: Sertić Z; Institute for Emergency Medicine Krapina-Zagorje County, 49 000 Krapina, Croatia., Lucijanić M; School of Medicine, University of Zagreb, 10 000 Zagreb, Croatia.; Clinical Hospital Dubrava, 10 000 Zagreb, Croatia., Bašić-Kinda S; University Hospital Centre Zagreb, 10 000 Zagreb, Croatia., Serventi Seiwerth R; University Hospital Centre Zagreb, 10 000 Zagreb, Croatia., Periša V; University Hospital Centre Osijek, 31 000 Osijek, Croatia.; Faculty of Medicine Osijek, University J.J. Strossmayer Osijek, 31 000 Osijek, Croatia., Sertić D; University Hospital Centre Zagreb, 10 000 Zagreb, Croatia., Coha B; General Hospital 'Dr. Josip Benčević' Slavonski Brod, 35 000 Slavonski Brod, Croatia., Pulanić D; School of Medicine, University of Zagreb, 10 000 Zagreb, Croatia.; University Hospital Centre Zagreb, 10 000 Zagreb, Croatia., Perić Z; School of Medicine, University of Zagreb, 10 000 Zagreb, Croatia.; University Hospital Centre Zagreb, 10 000 Zagreb, Croatia., Desnica L; University Hospital Centre Zagreb, 10 000 Zagreb, Croatia., Mikulić M; University Hospital Centre Zagreb, 10 000 Zagreb, Croatia., Vodanović M; University Hospital Centre Zagreb, 10 000 Zagreb, Croatia., Radman-Livaja I; University Hospital Centre Zagreb, 10 000 Zagreb, Croatia., Šegulja D; University Hospital Centre Zagreb, 10 000 Zagreb, Croatia., Rogić D; University Hospital Centre Zagreb, 10 000 Zagreb, Croatia., Valković T; University Hospital Center Rijeka, 51 000 Rijeka, Croatia.; Medical School, University of Rijeka, 51 000 Rijeka, Croatia., Aurer I; School of Medicine, University of Zagreb, 10 000 Zagreb, Croatia.; University Hospital Centre Zagreb, 10 000 Zagreb, Croatia., Duraković N; School of Medicine, University of Zagreb, 10 000 Zagreb, Croatia.; University Hospital Centre Zagreb, 10 000 Zagreb, Croatia.

Publikováno v: Biomedicines [Biomedicines] 2022 Nov 11; Vol. 10 (11). Date of Electronic Publication: 2022 Nov 11.

Use of eltrombopag in aplastic anemia in Europe

Autor: Ecsedi, M., Lengline, E., Knol-Bout, C., Bosman, P., Eikema, D.J., Afanasyev, B., Maschan, A., Dreger, P., Halkes, C.J.M., Drexler, B., Cortelezzi, A., Drenou, B., Patriarca, A., Bruno, B., Onofrillo, D., Lanino, E., Pulanic, D., Serventi-Seiwerth, R., Garnier, A., Ljungman, P., Bonifazi, F., Giammarco, S., Tournilhac, O., Pioltelli, P., Rovo, A., Risitano, A.M., Latour, R.P. de, Dufour, C., Passweg, J., EBMT SAA Working Party

Publikováno v: Ecsedi, Matyas; Lengline, Étienne; Knol-Bout, Cora; Bosman, Paul; Eikema, Dirk-Jan; Afanasyev, Boris; Maschan, Alexei; Dreger, Peter; Halkes, Constantijn J M; Drexler, Beatrice; Cortelezzi, Agostino; Drénou, Bernard; Patriarca, Andrea; Bruno, Benedetto; Onofrillo, Daniela; Lanino, Edoardo; Pulanic, Drazen; Serventi-Seiwerth, Ranka; Garnier, Alice; Ljungman, Per; ... (2019). Use of eltrombopag in aplastic anemia in Europe. Annals of hematology, 98(6), pp. 1341-1350. Springer-Verlag 10.1007/s00277-019-03652-8
Annals of Hematology
Annals of Hematology, Springer Verlag, 2019, 98 (6), pp.1341-1350. ⟨10.1007/s00277-019-03652-8⟩
Annals of Hematology, 98(6), 1341-1350. SPRINGER

Eltrombopag (ELT), an oral thrombopoietin receptor agonist, has recently emerged as a promising new drug for the treatment of aplastic anemia (AA). How ELT is used outside of clinical trials in the real-world setting and results of this treatment are

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31aa821628e23ecccb37ba20970a88ab
https://boris.unibe.ch/133197/1/s00277-019-03652-8.pdf

Various approaches for accessing the influence of human leukocyte antigens disparity in haploidentical stem cell transplantation.

Autor: Grubic Z; Tissue Typing Centre, Clinical Department for Transfusion Medicine and Transplantation Biology, University Hospital Centre Zagreb, Zagreb, Croatia., Burek Kamenaric M; Tissue Typing Centre, Clinical Department for Transfusion Medicine and Transplantation Biology, University Hospital Centre Zagreb, Zagreb, Croatia., Maskalan M; Tissue Typing Centre, Clinical Department for Transfusion Medicine and Transplantation Biology, University Hospital Centre Zagreb, Zagreb, Croatia., Durakovic N; Department of Hematology, Internal Clinic, University Hospital Centre Zagreb, Zagreb, Croatia., Vrhovac R; Department of Hematology, Internal Clinic, University Hospital Centre Zagreb, Zagreb, Croatia., Stingl Jankovic K; Tissue Typing Centre, Clinical Department for Transfusion Medicine and Transplantation Biology, University Hospital Centre Zagreb, Zagreb, Croatia., Serventi Seiwerth R; Department of Hematology, Internal Clinic, University Hospital Centre Zagreb, Zagreb, Croatia., Zunec R; Tissue Typing Centre, Clinical Department for Transfusion Medicine and Transplantation Biology, University Hospital Centre Zagreb, Zagreb, Croatia.

Publikováno v: International journal of laboratory hematology [Int J Lab Hematol] 2022 Jun; Vol. 44 (3), pp. 547-557. Date of Electronic Publication: 2022 Mar 06.

Aloimunizacije kod pacijenata liječenih transplantacijom alogenih krvotvornih matičnih stanica

Autor: Raos M, Bojanic I, Serventi Seiwerth R, Golubic Cepulic B

određen stupanj nepodudarnosti u eritrocitnim antigenima. Velika, mala i obostrana nepodudarnost u ABO sustavu mogu u posttrasplantacijskom periodu uzrokovati akutnu hemolizu ili odgođen oporavak eritropoeze. Aloprotutijela „non anti-A/B“ mogu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::acca99951a55dd8e63a1bcd7f85559fd
https://www.bib.irb.hr/1077847

B regulatory cells and monocyte subpopulations in patients with chronic graft-vs-host disease.

Autor: Babić A; Antonija Babić, Department of Laboratory Diagnostics, University Hospital Centre Zagreb, Kišpatićeva 12, 10000 Zagreb, ababic2@kbc-zagreb.hr., Kurić L, Zelić Kerep A, Desnica L, Lelas A, Milošević M, Serventi-Seiwerth R, Duraković N, Peric Z, Mravak Stipetić M, Bilic E, Čeović R, Barešić M, Vukić T, Ljubas Kelečić D, Mazić S, Bojanić I, Hećimović A, Bilic E, Zadro R, Vrhovac R, Pavletic SZ, Batinić D, Pulanić D

Publikováno v: Croatian medical journal [Croat Med J] 2021 Apr 30; Vol. 62 (2), pp. 154-164.